Your browser doesn't support javascript.
loading
Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations.
Austin, Rebecca J; Straube, Jasmin; Bruedigam, Claudia; Pali, Gabor; Jacquelin, Sebastien; Vu, Therese; Green, Joanne; Gräsel, Julius; Lansink, Lianne; Cooper, Leanne; Lee, Shin-Jye; Chen, Nien-Tsu; Lee, Chung-Wei; Haque, Ashraful; Heidel, Florian H; D'Andrea, Richard; Hill, Geoff R; Mullally, Ann; Milsom, Michael D; Bywater, Megan; Lane, Steven W.
Afiliación
  • Austin RJ; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Straube J; The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Bruedigam C; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Pali G; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Jacquelin S; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Vu T; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Green J; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Gräsel J; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Lansink L; Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH (HI-STEM), 69120, Heidelberg, Germany.
  • Cooper L; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Lee SJ; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Chen NT; PharmaEssentia Co, Taipei, Taiwan.
  • Lee CW; PharmaEssentia Co, Taipei, Taiwan.
  • Haque A; PharmaEssentia, USA, LLC, Burlington, MA, USA.
  • Heidel FH; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • D'Andrea R; Leibniz-Institute on Aging-Fritz Lipmann Institute (FLI), Beutenbergstrasse 11, 07745, Jena, Germany.
  • Hill GR; Innere Medizin 2, Hämatologie und Onkologie, Universitätsklinikum Jena, 07747, Jena, Germany.
  • Mullally A; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
  • Milsom MD; Cancer Program, QIMR Berghofer Medical Research Institute, 300 Herston Rd, Herston, Brisbane, QLD, 3006, Australia.
  • Bywater M; Fred Hutchinson Cancer Centre, Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Lane SW; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Leukemia ; 34(4): 1075-1089, 2020 04.
Article en En | MEDLINE | ID: mdl-31732720
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazoles / Células Madre Hematopoyéticas / Interferón-alfa / Factor de Transcripción STAT1 / Janus Quinasa 2 / Mutación / Trastornos Mieloproliferativos Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirazoles / Células Madre Hematopoyéticas / Interferón-alfa / Factor de Transcripción STAT1 / Janus Quinasa 2 / Mutación / Trastornos Mieloproliferativos Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article